This report offers companies, investors, policymakers, and stakeholders crucial insight into the specificities of Swiss pharmaceuticals, biotech, and healthcare, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, global affiliate heads, and founders of innovative local SMEs.

In spite of high operating costs and a sometimes-byzantine regulatory environment, major MNCs are flocking to establish regional headquarters in a country frequently ranked the most innovative in the world. Complementary thriving ecosystems of biotech startups, contract research and manufacturing organizations, as well as a whole host of niche service providers has also sprung up across Switzerland, many of which are featured in the report.